Viewing Study NCT06140667



Ignite Creation Date: 2024-05-06 @ 7:48 PM
Last Modification Date: 2024-10-26 @ 3:14 PM
Study NCT ID: NCT06140667
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2023-10-31

Brief Title: Laryseal Pro LMA Versus Ambu Aura Gain LMA in Elective Ophthalmological Surgeries
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Comparative Evaluation of the Laryseal TM Pro Laryngeal Mask Airway With Ambu Aura Gain Laryngeal Mask Airway in Anesthetized Paralyzed Adult Patients Undergoing Elective Ophthalmological Surgeries A Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Tracheal intubation is considered the gold standard for protecting the airway As the supraglottic airway devices SADs could be inserted without laryngoscopy so that SADs with different designs and safety issues could be used to manage difficult airways in anesthesia and emergency medicine with continuous patient oxygenation ventilation less hemodynamic stress response and less postoperative complications Many health care providers do not have the requisite knowledge and enough practice to perform safe and quick intubation For these providers SADs can be a valid alterative especially in untrained personnel or when tracheal intubation is impossibe

Both devices are with a cuff modified to improve the seal around the glottis and a drainage tube to provide a bypass channel for regurgitated gastric contents prevent gastric insufflation and allow the passage of a gastric tube These features are designed to improve the safety of the mask and broaden its scope especially when used with positive pressure ventilation

The AuraGain is Ambu ꞌs 3rd generation disposable laryngeal mask satisfying 3 fundamental airway management needs by integrating gastric access channel for managing gastric content and intubation capability using standard ET-tubes in an anatomically curved single-use device that facilitates rapid establishment of a safe airway through integrated bite absorption area that could prevent airway occlusion Other characters include pilot balloon that identifies mask size and provides tactile indication of degree of inflation navigation marks for guiding flexible scope and is made of phthalate-free material Its thin and soft cuff is designed to deliver high seal pressure up to 40 cmH2O It was presented in the clinical market in sizes 3 4 5 and 6 according to the body weight size 3 30-50 kg size 4 50-70 kg size 5 70-100 kg and size 6 100 kg that can accept tracheal tube in sizes ranging from 65 up to 75 and 8mm inner diameter respectively with maximum suction catheter size of 16 Fr

The LarysealTM Pro is the new generation mask for safe and effective airway management as it could reduce the risk of aspiration by the integrated suction catheter port to allow effective removal of fluids and gastric contents So that it could be a promising airway device as its symmetrical cuff and tube contoured to match the oropharyngeal anatomy for quick and easy first time insertion success It could be applied in both routine and advanced airway management for patients with a higher risk of a difficult airway unexpected intubation difficulties beside to airway control during anesthesia It was presented in the clinical market in sizes 3 4 and 5 according to the body weight size 3 30-50Kg size 4 50-70 Kg and size 570-100Kg that can accept larger tracheal tube up to 75 and 8mm inner diameter respectively with maximum suction catheter size of 16 Fr The Laryseal pro could provide a rapid and secure airway management and improve patient safety with gastric access reducing the risk of pulmonary aspiration in addition to speeding up the ETT tube placement if needed with a unique guide system beside to integrated fenestrated flap that protects from blockage with minimal increase in flow resistance All these features of laryseal pro allow quick easy first time insertion success

After approval of the Local Ethical Committee and obtaining an informed written consent from every patient then patients will be categorized randomly into two equal groups using the computer allocation software to be put into opaque closed-envelopes GL n27 Laryseal TM Pro GA n27 Ambu Aura Gain
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None